FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2182104156> ?p ?o ?g. }

• W2182104156 endingPage "6" @default.
• W2182104156 startingPage "1002" @default.
• W2182104156 abstract "A prospective study to evaluate the role of fludarabine alone or in combination with idarubicin in untreated patients with mantle cell lymphoma (MCL).Twenty-nine untreated patients with mantle cell lymphoma were stochastically treated with intravenous fludarabine at a dose of 25 mg/m(2)/day for 5 days (11 patients) or with a combination of fludarabine and idarubicin (FLU-ID) (fludarabine 25 mg/m(2) i.v. on days 1 to 3 and idarubicin 12 mg/m(2) i.v. on day 1 (18 patients). For both regimens, cycles were given at three-week intervals for a total of six courses. According to the International Prognostic Index, the most part of high-intermediate and high risk factor patients were in the FLU-ID subset: 7 (39%) patients vs. 2 (18%) in the fludarabine alone subset.Of the 29 patients, 8 (28%) obtained a complete response and 10 (35%) a partial response, with an overall response rate of 63%. The remaining 11 (37%) patients did not respond to the therapy. The overall response rates were 64% (7 patients) in the fludarabine group and 61% (11 patients) in the FLU-ID group. The complete response rate was 27% (3 patients) for fludarabine and 28% (5 patients) for FLU-ID. The toxicity was mild in terms of neutropenia and infections, and no fatalities occurred due to drug-induced side effects.These results suggest the efficacy of fludarabine alone or in combination with idarubicin in MCL patients. It will be important to increase this experience and to assess other fludarabine-containing regimens, in particular with cyclophosphamide plus idarubicin and with mitoxantrone and or cyclophosphamide, to test the true role of this approach in MCL." @default.
• W2182104156 created "2016-06-24" @default.
• W2182104156 creator A5000093989 @default.
• W2182104156 creator A5002237220 @default.
• W2182104156 creator A5004888416 @default.
• W2182104156 creator A5008693201 @default.
• W2182104156 creator A5028241549 @default.
• W2182104156 creator A5029563827 @default.
• W2182104156 creator A5031758293 @default.
• W2182104156 creator A5033359713 @default.
• W2182104156 creator A5040968192 @default.
• W2182104156 creator A5045487299 @default.
• W2182104156 creator A5046307290 @default.
• W2182104156 creator A5050359020 @default.
• W2182104156 creator A5058491107 @default.
• W2182104156 creator A5071128692 @default.
• W2182104156 creator A5080224543 @default.
• W2182104156 creator A5082960835 @default.
• W2182104156 date "1999-11-01" @default.
• W2182104156 modified "2023-10-18" @default.
• W2182104156 title "Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients." @default.
• W2182104156 cites W101474840 @default.
• W2182104156 cites W1779642901 @default.
• W2182104156 cites W1785340630 @default.
• W2182104156 cites W1831621090 @default.
• W2182104156 cites W1848698181 @default.
• W2182104156 cites W1911120442 @default.
• W2182104156 cites W1921096083 @default.
• W2182104156 cites W1979300931 @default.
• W2182104156 cites W2076668534 @default.
• W2182104156 cites W2087242841 @default.
• W2182104156 cites W2095113053 @default.
• W2182104156 cites W2100195980 @default.
• W2182104156 cites W2107202569 @default.
• W2182104156 cites W21149459 @default.
• W2182104156 cites W2148663566 @default.
• W2182104156 cites W2182960962 @default.
• W2182104156 cites W2184371417 @default.
• W2182104156 cites W2185495810 @default.
• W2182104156 cites W2210611916 @default.
• W2182104156 cites W2241314352 @default.
• W2182104156 cites W2254608986 @default.
• W2182104156 cites W2266889995 @default.
• W2182104156 cites W2278012184 @default.
• W2182104156 cites W2309937882 @default.
• W2182104156 cites W2319826005 @default.
• W2182104156 cites W2398933683 @default.
• W2182104156 cites W2411708266 @default.
• W2182104156 cites W2411908529 @default.
• W2182104156 cites W2605539363 @default.
• W2182104156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10553160" @default.
• W2182104156 hasPublicationYear "1999" @default.
• W2182104156 type Work @default.
• W2182104156 sameAs 2182104156 @default.
• W2182104156 citedByCount "6" @default.
• W2182104156 countsByYear W21821041562012 @default.
• W2182104156 countsByYear W21821041562017 @default.
• W2182104156 crossrefType "journal-article" @default.
• W2182104156 hasAuthorship W2182104156A5000093989 @default.
• W2182104156 hasAuthorship W2182104156A5002237220 @default.
• W2182104156 hasAuthorship W2182104156A5004888416 @default.
• W2182104156 hasAuthorship W2182104156A5008693201 @default.
• W2182104156 hasAuthorship W2182104156A5028241549 @default.
• W2182104156 hasAuthorship W2182104156A5029563827 @default.
• W2182104156 hasAuthorship W2182104156A5031758293 @default.
• W2182104156 hasAuthorship W2182104156A5033359713 @default.
• W2182104156 hasAuthorship W2182104156A5040968192 @default.
• W2182104156 hasAuthorship W2182104156A5045487299 @default.
• W2182104156 hasAuthorship W2182104156A5046307290 @default.
• W2182104156 hasAuthorship W2182104156A5050359020 @default.
• W2182104156 hasAuthorship W2182104156A5058491107 @default.
• W2182104156 hasAuthorship W2182104156A5071128692 @default.
• W2182104156 hasAuthorship W2182104156A5080224543 @default.
• W2182104156 hasAuthorship W2182104156A5082960835 @default.
• W2182104156 hasConcept C126322002 @default.
• W2182104156 hasConcept C141071460 @default.
• W2182104156 hasConcept C2776694085 @default.
• W2182104156 hasConcept C2776755627 @default.
• W2182104156 hasConcept C2777063308 @default.
• W2182104156 hasConcept C2777525834 @default.
• W2182104156 hasConcept C2778041864 @default.
• W2182104156 hasConcept C2778476033 @default.
• W2182104156 hasConcept C2778559949 @default.
• W2182104156 hasConcept C2779117419 @default.
• W2182104156 hasConcept C2779263901 @default.
• W2182104156 hasConcept C2779338263 @default.
• W2182104156 hasConcept C2781413609 @default.
• W2182104156 hasConcept C71924100 @default.
• W2182104156 hasConcept C90924648 @default.
• W2182104156 hasConceptScore W2182104156C126322002 @default.
• W2182104156 hasConceptScore W2182104156C141071460 @default.
• W2182104156 hasConceptScore W2182104156C2776694085 @default.
• W2182104156 hasConceptScore W2182104156C2776755627 @default.
• W2182104156 hasConceptScore W2182104156C2777063308 @default.
• W2182104156 hasConceptScore W2182104156C2777525834 @default.
• W2182104156 hasConceptScore W2182104156C2778041864 @default.
• W2182104156 hasConceptScore W2182104156C2778476033 @default.
• W2182104156 hasConceptScore W2182104156C2778559949 @default.

• next